NRX:TSXV, NurExone Biologic Inc.

NRX stock overview

NurExone Biologic Inc. (NRX:TSXV) closed at $0.465 on November 12, 2026, unchanged on the day. The stock trades 38.8% below its 52-week high of $0.760 and 6.9% above its 52-week low of $0.435. Over the past year, it lost 33.6%. NurExone Biologic Inc. is part of the Health Care sector.

Key figures

Price
$0.465
Day change
0.00%
Volume
10,004
Average volume
22,140
Market cap
42M+
52-week range
$0.435 – $0.760
50-day average
$0.578
200-day average
$0.586

Price action over the past year

In 252 trading sessions since November 13, 2025, NRX closed higher on 76 days (30%). Its best day was August 18, 2026 (+26.32%) and its worst was September 28, 2026 (-13.43%). The stock moved 10% or more in a single session 10 times. It opened at least 5% above the previous day's high 4 times.

Recent signals

NRX news

About NurExone Biologic Inc.

NurExone Biologic Inc is engaged in the in development of novel, biologic and minimal-invasive treatment for Spinal Cord Injury and Traumatic Brain Injury.

Similar stocks

Find more stocks like NRX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.